“Whistle-blowers” are invaluable and their right to speak requires zealous protection. But too often the whistle-blower is deified before he or she is vetted. Reactive idolatry of FDA whistle-blowers is hazardous.
The anointing of Dr. Robert Smith, an FDA whistle-blower, is well under way. Reportedly, his accomplishments at the FDA include “caustic … hammering away at his bosses.”
I don’t know Dr. Smith, and I express no opinion of him.
This is the concern: The line between a valued whistle-blower and a disruptive blowhard is hard to draw. Jumping rashly at bait tossed out by a disgruntled FDA “scientist” can cost lots of taxpayer money and adversely affect national health care.